Meyka Pro banner
Reliance Home Finance Limited

Stay Updated with the Latest Reliance Home Finance Limited RHFL.NS News in Real Time

Find RHFL.NS news now at Meyka AI. Stay informed with the latest Reliance Home Finance Limited stocks updates, including price news, market analysis, and expert insights.

RHFL.NSNSE
Financial ServicesFinancial - Mortgages
1.85
0.07(3.93%)
Indian Market opens in 6h 34m
Father Pushes ‘Lily’s Law’ After Teen Hiker Dies in NSW Bushland
📅 in about 2 hours

Father Pushes ‘Lily’s Law’ After Teen Hiker Dies in NSW Bushland

After 18-year-old Lily Hooper’s death in NSW bushland, her father pushes for ‘Lily’s Law’ to require GPS trackers and safety beacons for hikers. NSW Premier Chris Minns pledges to honour her memory.

Read more 12
Canterbury Bulldogs Face COVID Crisis With 10 Players Out Before Penrith Clash
📅 3 hours ago

Canterbury Bulldogs Face COVID Crisis With 10 Players Out Before Penrith Clash

Ten Canterbury Bulldogs players miss training due to COVID-19 outbreak ahead of crucial Penrith clash. Club faces major disruption with finals hopes on the line.

Read more 12
BLS International (NSE: BLS) Sinks 13% to ₹236 Amid Spanish Visa Fraud Investigation; Firm Denies Wrongdoing
📅 3 hours ago

BLS International (NSE: BLS) Sinks 13% to ₹236 Amid Spanish Visa Fraud Investigation; Firm Denies Wrongdoing

BLS International shares fell nearly 14% to ₹233.47 on the NSE on August 24, 2026, after reports linked the company to an expanded Spanish National Court investigation into alleged visa fraud in Algiers. The sharp decline has put the BLS share price under fresh pressure. BLS International has denied any wrongdoing. The company said its…

Read more 12
Hindustan Zinc (NSE: HINDZINC) Advances 2.5% to ₹609.60, Extends Rally to Third Straight Session
📅 4 hours ago

Hindustan Zinc (NSE: HINDZINC) Advances 2.5% to ₹609.60, Extends Rally to Third Straight Session

Hindustan Zinc shares rose 2.47% to ₹609.60 on Monday, August 24, 2026. The stock extended its rally to a third consecutive session, outperforming the broader market. Hindustan Zinc is up 40.23% over the past year, against a 3.13% drop in the Nifty 50. Silver Strength Keeps Driving the Rally Hindustan Zinc’s Q1 FY27 results, released…

Read more 12
Heranba Industries (NSE: HERANBA) Jumps 9.5% to ₹180.60 on ₹25 Crore Agrochem Unit Investment
📅 5 hours ago

Heranba Industries (NSE: HERANBA) Jumps 9.5% to ₹180.60 on ₹25 Crore Agrochem Unit Investment

Heranba Industries shares jumped 9.53% to ₹180.60 on Monday, August 24, 2026. The rally followed a Q1 FY27 profit turnaround alongside a fresh ₹25 crore investment plan. Heranba Industries also returned to profitability after a weak Q4 FY26. Q1 FY27 Results Drive the Rally Heranba Industries (HERANBA.NS) posted consolidated net profit of ₹7.14 crore in…

Read more 12
Xiaomi (HK: 1810) Launches In-House Xring O3 Chip and Partners with TSMC for Production
📅 5 hours ago

Xiaomi (HK: 1810) Launches In-House Xring O3 Chip and Partners with TSMC for Production

Xiaomi unveiled its Xring O3 chip on August 24, 2026, adding another in-house processor to its growing semiconductor effort. Sources familiar with the plans say TSMC will manufacture the chip using 3nm technology. The processor is expected to power Xiaomi’s next flagship foldable, with initial shipments estimated at 200,000 to 300,000 units. Developing its own…

Read more 12
Sony Faces PlayStation Blackout as Gamers Protest Disc Phase-Out by 2028
📅 5 hours ago

Sony Faces PlayStation Blackout as Gamers Protest Disc Phase-Out by 2028

PlayStation gamers boycott Sony through August 30 over plans to end physical disc production in 2028. Sony’s licensing emails spark debate on digital ownership rights.

Read more 12
Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  
📅 6 hours ago

Hanmi Pharm (KRX: 128940) Hits 30% Daily Limit on $2.3B Obesity Drug Licensing Deal with Genentech  

Hanmi Pharm shares surged 30% on August 24, 2026, hitting the daily price limit after the South Korean drugmaker announced a licensing deal with Genentech worth up to $2.3 billion. The agreement covers HM17321, an experimental obesity treatment designed to reduce body fat while preserving muscle mass. Hanmi will receive $190 million upfront, while Genentech…

Read more 12
Samsung (KRX: 005930) Slumps 8.8% as $80 Billion Shareholder Return Plan Underwhelms Markets
📅 6 hours ago

Samsung (KRX: 005930) Slumps 8.8% as $80 Billion Shareholder Return Plan Underwhelms Markets

Samsung Electronics shares fell as much as 9.4% to 255,000 won on Monday, August 24, 2026. The stock later settled around an 8.8% decline, making Samsung the biggest weight on the KOSPI index. The selloff followed Friday’s announcement of a 90 trillion to 110 trillion won ($65 billion to $80 billion) shareholder return plan. Investors…

Read more 12

RHFL.NS News FAQ